Neonatal Jaundice in Low- and Middle-Income Countries: Lessons and Future Directions from the 2015 Don Ostrow Trieste Yellow Retreat

Neonatology

Volumn 110, Issue 3, 2016, Pages 172-180

  Greco, Chiara ^a   Arnolda, Gaston ^j   Boo, Nem Yun ^c   Iskander, Iman F ^d   Okolo, Angela A ^e   Rohsiswatmo, Rinawati ^f   Shapiro, Steven M ^g   Watchko, Jon ^h   Wennberg, Richard P ^a,i   Tiribelli, Claudio ^a,b   Coda Zabetta, Carlos D ^a  

^a Bilimetrix   (Italy)

^b Fondazione Italiana Fegato Centro Studi Fegato   (Italy)

^c UNIVERSITI TUNKU ABDUL RAHMAN   (Malaysia)

^d Cairo University   (Egypt)

^e FEDERAL MEDICAL CENTER   (Nigeria)

^f CIPTO MANGUNKUSUMO HOSPITAL   (Indonesia)

^g CHILDREN S MERCY HOSPITAL   (United States)

^h UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^j Thrive Networks   (United States)

more..

Author keywords

Acute bilirubin encephalopathy; Kernicterus; Low and middle income countries; Neonatal jaundice; Severe hyperbilirubinemia

Indexed keywords

BILIRUBIN BLOOD LEVEL; CANOPY; CASE FATALITY RATE; DISEASE CLASSIFICATION; DISEASE SEVERITY; GEOGRAPHIC DISTRIBUTION; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HUMAN; HYPERBILIRUBINEMIA; IMMUNOPROPHYLAXIS; INCIDENCE; KERNICTERUS; LOW INCOME COUNTRY; MIDDLE INCOME COUNTRY; NEWBORN JAUNDICE; PHOTOTHERAPY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SURVIVAL RATE; BLOOD; DEVELOPING COUNTRY; EDUCATION; JAUNDICE, NEONATAL; NEWBORN; ORGANIZATION; STATISTICS AND NUMERICAL DATA;

BILIRUBIN;

BILIRUBIN; CONGRESSES AS TOPIC; DEVELOPING COUNTRIES; HEALTH PERSONNEL; HUMANS; INCIDENCE; INFANT, NEWBORN; JAUNDICE, NEONATAL; PHOTOTHERAPY;

EID: 84966784692     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000445708     Document Type: Review

References (81)

1. Olusanya BO, Ogunlesi TA, Slusher TM: Why is kernicterus still a major cause of death and disability in low-income and middle-income countries? Arch Dis Child 2014; 99: 1117-1121.
2. Burke BL, Robbins JM, Bird TM, Hobbs CA, Nesmith C, Tilford JM: Trends in hospitalizations for neonatal jaundice and kernicterus in the United States, 1988-2005. Pediatrics 2009; 123: 524-532.
3. Young Infants Clinical Signs Study Group: Clinical signs that predict severe illness in children under age 2 months: a multicentre study. Lancet Lond Engl 2008; 371: 135-142.
4. Hansen TWR: Mechanisms of bilirubin toxicity: clinical implications. Clin Perinatol 2002; 29: 765-778
5. Newman TB, Maisels MJ: Evaluation and treatment of jaundice in the term newborn: a kinder, gentler approach. Pediatrics 1992; 89: 809-818.
6. Volpe JJ: Neurology of the Newborn. Amsterdam, Elsevier Health Sciences, 2008.
7. Maisels MJ: Managing the jaundiced newborn: a persistent challenge. CMAJ 2015; 187: 335-343.
8. Barrington KJ, Sankaran K; Canadian Paediatric Society Fetus and Newborn Committee: Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks' gestation)-summary. Paediatr Child Health 2007; 12: 401-407.
9. World Health Organization: WHO recommendations on postnatal care of the mother and newborn 2014 (cited December 23, 2015). h t t p : / / w w w. w h o. i n t / i r i s / h a n-dle/10665/97603.
10. World Health Organization: Pocket Book of Hospital Care for Children: guidelines for the management of common childhood illnesses. Geneva, World Health Organization, 2013.
11. NICE/National Institute for Health and Care Excellence: Neonatal jaundice 2010. https:// www.nice.org.uk/guidance/cg98/evidence/ full-guideline-245411821.
12. NICE/National Institute for Health and Care Excellence: Updated neonatal jaundice pathway 2014 (cited December 23, 2015). http:// pathways.nice.org.uk/pathways/neonataljaundice.
13. NICE/National Institute for Health and Care Excellence: Updated postnatal care 2014 (cited December 23, 2015). https://www.nice.org. uk/guidance/cg37.
14. Subcommittee on Hyperbilirubinemia: Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114: 297-316.
15. Screening of infants for hyperbilirubinemia to prevent chronic bilirubin encephalopathy: US Preventive Services Task Force recommendation statement. Pediatrics 2009; 124: 1172-1177.
16. Bhutani VK; American Academy of Pediatrics Committee on Fetus and Newborn: Phototherapy to prevent severe neonatal hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2011; 128:e1046-e1052.
17. Whyte R: Safe discharge of the late preterm infant. Paediatr Child Health 2010; 15: 655-666.
18. NANN Board of Directors: Prevention of acute bilirubin encephalopathy and kernicterus in newborns. Position Statement #3049. Adv Neonatal Care 2011; 11(suppl):S3-S9.
19. Queensland Health Statewide Maternity and Neonatal Clinical Guidelines Program: Neonatal jaundice clinical guideline supplement 2012 (cited December 23, 2015). https://www. health.qld.gov.au/qcg/documents/s-jaundice. pdf.
20. Olusanya BO, Osibanjo FB, Mabogunje CA, Slusher TM, Olowe SA: The burden and management of neonatal jaundice in Nigeria: a scoping review of the literature. Niger J Clin Pract 2016; 19: 1-17.
21. Bhutani VK: Editorial: building evidence to manage newborn jaundice worldwide. Indian J Pediatr 2012; 79: 253-255.
22. Bhutani VK, Vilms RJ, Hamerman-Johnson L: Universal bilirubin screening for severe neonatal hyperbilirubinemia. J Perinatol 2010; 30(suppl):S6-S15.
23. Ebbesen F, Andersson C, Verder H, Grytter C, Pedersen-Bjergaard L, Petersen JR, et al: Extreme hyperbilirubinaemia in term and near-term infants in Denmark. Acta Paediatr 2005; 94: 59-64.
24. Manning D, Todd P, Maxwell M, Jane Platt M: Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland. Arch Dis Child Fetal Neonatal Ed 2007; 92:F342-F346.
25. Sgro M, Campbell D, Shah V: Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ 2006; 175: 587-590.
26. Zoubir S, Mieth RA, Berrut S, Roth-Kleiner M; Swiss Paediatric Surveillance Unit: Incidence of severe hyperbilirubinaemia in Switzerland: a nationwide population-based prospective study. Arch Dis Child Fetal Neonatal Ed 2011; 96:F310-F311.
27. Bjerre JV, Petersen JR, Ebbesen F: Surveillance of extreme hyperbilirubinaemia in Denmark. A method to identify the newborn infants. Acta Paediatr 2008; 97: 1030-1034.
28. McGillivray A, Evans N: Severe neonatal jaundice: is it a rare event in Australia? J Paediatr Child Health 2012; 48: 801-807.
29. Gotink MJ, Benders MJ, Lavrijsen SW, Rodrigues Pereira R, Hulzebos CV, Dijk PH: Severe neonatal hyperbilirubinemia in the Netherlands. Neonatology 2013; 104: 137-142.
30. Bhutani VK, Johnson L: Kernicterus in the 21st century: frequently asked questions. J Perinatol 2009; 29(suppl 1):S20-S24.
31. Olusanya BO, Imam ZO, Emokpae AA, Iskander IF: Revisiting the criteria for exchange transfusion for severe neonatal hyperbilirubinemia in resource-limited settings. Neonatology 2016; 109: 97-104.
32. Bhutani VK, Zipursky A, Blencowe H, Khanna R, Sgro M, Ebbesen F, et al: Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels. Pediatr Res 2013; 74(suppl 1):86-100.
33. Gamaleldin R, Iskander I, Seoud I, Aboraya H, Aravkin A, Sampson PD, et al: Risk factors for neurotoxicity in newborns with severe neonatal hyperbilirubinemia. Pediatrics 2011; 128:e925-e931.
34. Iskander I, Gamaleldin R, El Houchi S, El Shenawy A, Seoud I, El Gharbawi N, et al: Serum bilirubin and bilirubin/albumin ratio as predictors of bilirubin encephalopathy. Pediatrics 2014; 134:e1330-e1339.
35. Simiyu DE: Morbidity and mortality of neonates admitted in general paediatric wards at Kenyatta National Hospital. East Afr Med J 2003; 80: 611-616.
36. Mwaniki MK, Gatakaa HW, Mturi FN, Chesaro CR, Chuma JM, Peshu NM, et al: An increase in the burden of neonatal admissions to a rural district hospital in Kenya over 19 years. BMC Public Health 2010; 10: 591.
37. Ugwu RO, Eneh AU, Oruamabo RS: Blood transfusion therapy in neonates admitted into the Special Care Baby Unit (SCBU) of University of Port Harcourt Teaching Hospital, Port Harcourt. Niger J Med 2006; 15: 401-405.
38. Ojukwu JU, Abonyi LE, Ugwu J, Orji IK: Neonatal septicemia in high risk babies in South-Eastern Nigeria. J Perinat Med 2006; 34: 166-172.
39. Owa JA, Osinaike AI: Neonatal morbidity and mortality in Nigeria. Indian J Pediatr 1998; 65: 441-449.
40. Okechukwu AA, Achonwa A: Morbidity and mortality patterns of admissions into the Special Care Baby Unit of University of Abuja Teaching Hospital, Gwagwalada, Nigeria. Niger J Clin Pract 2009; 12: 389-394.
41. Udo JJ, Anah MU, Ochigbo SO, Etuk IS, Ekanem AD: Neonatal morbidity and mortality in Calabar, Nigeria: a hospital-based study. Niger J Clin Pract 2008; 11: 285-289.
42. Etuk SJ, Etuk IS, Ekott MI, Udoma EJ: Perinatal outcome in pregnancies booked for antenatal care but delivered outside health facilities in Calabar, Nigeria. Acta Trop 2000; 75: 29-33.
43. Omoigberale AI, Sadoh WE, Nwaneri DU: A 4-year review of neonatal outcome at the University of Benin Teaching Hospital, Benin City. Niger J Clin Pract 2010; 13: 321-325.
44. Ezeaka VC, Iroha EO: Physical health status of pupils in a school for the mentally disabled in Lagos. Niger Postgrad Med J 2003; 10: 238-242.
45. Owa JA, Adebami OJ, Fadero FF, Slusher TM: Irradiance readings of phototherapy equipment: Nigeria. Indian J Pediatr 2011; 78: 996-998.
46. Eneh AU, Ugwu RO: Perception of neonatal jaundice among women attending children out-patient and immunization clinics of the UPTH Port Harcourt. Niger J Clin Pract 2009; 12: 187-191.
47. Wei K-L, Yang Y-J, Yao Y-J, Du L-Z, Wang Q-H, Wang R-H, et al: Epidemiologic survey on hospitalized neonates in China. Transl Pediatr 2012; 1: 15-22.
48. Rasul CH, Hasan MA, Yasmin F: Outcome of neonatal hyperbilirubinemia in a tertiary care hospital in Bangladesh. Malays J Med Sci 2010; 17: 40-44.
49. Islam MN, Siddika M, Hossain MA, Bhuiyan MK, Ali MA: Morbidity pattern and mortality of neonates admitted in a tertiary level teaching hospital in Bangladesh. Mymensingh Med J 2010; 19: 159-162.
50. Dutta D, Bhattacharya MK, Bhattacharya SK, Chaudhuri A, Lahiri M, Mitra U, et al: Influence of admission weight on neonatal mortality amongst hospitalised neonates in Calcutta. J Indian Med Assoc 1992; 90: 308-309.
51. Bang AT, Bang RA, Baitule S, Deshmukh M, Reddy MH: Burden of morbidities and the unmet need for health care in rural neonates-a prospective observational study in Gadchiroli, India. Indian Pediatr 2001; 38: 952-965.
52. Myanmar Department of Health: Annual hospital statistics 2010-2011, 2013 (cited December 23, 2015). http://www.moh.gov.mm/ file/Annual%20Hospital%20Statistics%20 Report%202010-2011.pdf.
53. Arnolda G, Nwe HM, Trevisanuto D, Thin AA, Thein AA, Defechereux T, et al: Risk factors for acute bilirubin encephalopathy on admission to two Myanmar national paediatric hospitals. Matern Health Neonatol Perinatol 2015. DOI: 10.1186/s40748-015-0024-3.
54. Selvaraju S: Preliminary report: a survey on severe neonatal jaundice cases admitted to selected hospitals in Malaysia. Proc Natl Perinat Health Conf, 1999, pp 70-79.
55. Crowther C, Middleton P: Anti-D administration after childbirth for preventing Rhesus alloimmunisation. Cochrane Database Syst Rev 2000;CD000021.
56. Malla T, Singh S, Poudyal P, Sathian B, Bk G, Malla KK: A prospective study on exchange transfusion in neonatal unconjugated hyperbilirubinemia-in a tertiary care hospital, Nepal. Kathmandu Univ Med J 2015; 13: 102-108.
57. Louis D, More K, Oberoi S, Shah PS: Intravenous immunoglobulin in isoimmune haemolytic disease of newborn: an updated systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2014; 99:F325-F331.
58. Izetbegovic S: Occurrence of ABO and RhD incompatibility with Rh negative mothers. Mater Sociomed 2013; 25: 255-258.
59. Bhutani VK, Wong RJ: Bilirubin neurotoxicity in preterm infants: risk and prevention. J Clin Neonatol 2013; 2: 61-69.
60. Glucose-6-phosphate dehydrogenase deficiency. WHO Working Group. Bull World Health Organ 1989; 67: 601-611.
61. Olusanya BO, Neumann KJ, Saunders JE: The global burden of disabling hearing impairment: a call to action. Bull World Health Organ 2014; 92: 367-373.
62. Thaddeus S, Maine D: Too far to walk: maternal mortality in context. Soc Sci Med 1994; 38: 1091-1110.
63. Johnson LH, Bhutani VK, Brown AK: System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr 2002; 140: 396-403.
64. Kumar K, Sohaila A, Tikmani SS, Khan IA, Zafar A: Screening for G6PD deficiency among neonates with neonatal jaundice admitted to tertiary care center: a need in disguise. J Coll Physicians Surg Pak 2015; 25: 625-626.
65. M Abo El Fotoh WM, Rizk MS: Prevalence of glucose-6-phosphate dehydrogenase deficiency in jaundiced Egyptian neonates. J Matern Fetal Neonatal Med 2016; 3: 1-4.
66. Goyal M, Garg A, Goyal MB, Kumar S, Ramji S, Kapoor S: Newborn screening for G6PD deficiency: A 2-year data from North India. Indian J Public Health 2015; 59: 145-148.
67. Boo NY, Gan CY, Gian YW, Lim KSL, Lim MW, Krishna-Kumar H: Malaysian mothers' knowledge and practices on care of neonatal jaundice. Med J Malaysia 2011; 66: 239-243.
68. Ng SY, Chong SY: What do mothers know about neonatal jaundice? Knowledge, attitude and practice of mothers in Malaysia. Med J Malaysia 2014; 69: 252-256.
69. Ogunlesi TA, Abdul AR: Maternal knowledge and care-seeking behaviors for newborn jaundice in Sagamu, southwest Nigeria. Niger J Clin Pract 2015; 18: 33-40.
70. Slusher TM, Olusanya BO, Vreman HJ, Brearley AM, Vaucher YE, Lund TC, et al: A randomized trial of phototherapy with filtered sunlight in African neonates. N Engl J Med 2015; 373: 1115-1124.
71. Poon WB, Ho WLC, Yeo CL: Survey on parenting practices among Chinese in Singapore. Singapore Med J 2007; 48: 1006-1011.
72. Ogunfowora OB, Adefuye PO, Fetuga MB: What do expectant mothers know about neonatal jaundice? Int Electron J Health Educ 2006; 9: 134-140.
73. Khalesi N, Rakhshani F: Knowledge, attitude and behaviour of mothers on neonatal jaundice. J Pak Med Assoc 2008; 58: 671-674.
74. Amirshaghaghi A, Ghabili K, Shoja MM, Kooshavar H: Neonatal jaundice: knowledge and practice of Iranian mothers with icteric newborns. Pak J Biol Sci 2008; 11: 942-945.
75. Kuzniewicz MW, Escobar GJ, Wi S, Liljestrand P, McCulloch C, Newman TB: Risk factors for severe hyperbilirubinemia among infants with borderline bilirubin levels: a nested casecontrol study. J Pediatr 2008; 153: 234-240.
76. Rylance S, Yan J, Molyneux E: Can transcutaneous bilirubinometry safely guide phototherapy treatment of neonatal jaundice in Malawi? Paediatr Int Child Health 2014; 34: 101-107.
77. National Neonatology Forum of India: Management of neonatal hyperbilirubinemia (cited January 3, 2016). http://www.nnfi.org.
78. Coda Zabetta CD, Iskander IF, Greco C, Bellarosa C, Demarini S, Tiribelli C, et al: Bilistick: a low-cost point-of-care system to measure total plasma bilirubin. Neonatology 2013; 103: 177-181.
79. Thairu L, Wirth M, Lunze K: Innovative newborn health technology for resource-limited environments. Trop Med Int Health 2013; 18: 117-128.
80. Arnolda G, Thein AA, Trevisanuto D, Aung N, Nwe HM, Thin AA, et al: Evaluation of a simple intervention to reduce exchange transfusion rates among inborn and outborn neonates in Myanmar, comparing pre-and postintervention rates. BMC Pediatr 2015; 15: 216.
81. Ngerncham S, Jirapaet K, Suvonachai R, Chaweerat R, Wongsiridej P, Kolatat T: Effectiveness of conventional phototherapy versus Super light-emitting diodes phototherapy in neonatal hyperbilirubinemia. J Med Assoc Thai 2012; 95: 884-889.